The partnership with BARDA and JPEO-CBRND includes a $20 million investment for increased syringe and needle device production to support Operation Warp Speed vaccine program.

Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-01

The FDA and CISA announced a set of cybersecurity vulnerabilities referred to as "URGENT/11" that have the potential to introduce risks to certain medical devices or hospital networks.